User contributions for Aidan

From IDWiki
Search for contributionsExpandCollapse
⧼contribs-top⧽
⧼contribs-date⧽

(newest | oldest) View ( | ) (20 | 50 | 100 | 250 | 500)

13 December 2022

9 December 2022

  • 18:3418:34, 9 December 2022 diff hist +299‎ Pyoderma gangrenosum ‎No edit summary Tag: Visual edit
  • 18:2618:26, 9 December 2022 diff hist +1,239‎ N Pyoderma gangrenosum ‎ Created page with "== Diagnosis == === Diagnostic Criteria<ref>Maverakis E, Ma C, Shinkai K, Fiorentino D, Callen JP, Wollina U, Marzano AV, Wallach D, Kim K, Schadt C, Ormerod A, Fung MA, Steel A, Patel F, Qin R, Craig F, Williams HC, Powell F, Merleev A, Cheng MY. Diagnostic Criteria of Ulcerative Pyoderma Gangrenosum: A Delphi Consensus of International Experts. JAMA Dermatol. 2018 Apr 1;154(4):461-466. doi: [https://doi.org/10.1001/jamadermatol.2017.5980 10.1001/jamadermatol.2017.5980..." Tag: Visual edit

8 December 2022

5 December 2022

30 November 2022

27 November 2022

24 November 2022

23 November 2022

22 November 2022

21 November 2022

18 November 2022

17 November 2022

16 November 2022

15 November 2022

14 November 2022

13 November 2022

11 November 2022

10 November 2022

9 November 2022

  • 08:0208:02, 9 November 2022 diff hist +43‎ m Cefipime ‎No edit summary current Tag: Visual edit
  • 08:0108:01, 9 November 2022 diff hist +512‎ N Cefipime ‎ Created page with "== Background == * Cephalosporin antibiotic == Safety == === Adverse Drug Effects === * Neurotoxicity, which can include altered mental status, myoclonus, and non-convulsive status epilepticus<ref>Gozun Maan, Koichi Keitoku, Nobuhiko Kimura, Haruki Sawada, Andrew Pham, Jihun Yeo, Hideharu Hagiya, Yoshito Nishimura, Cefepime-induced neurotoxicity: systematic review, ''Journal of Antimicrobial Chemotherapy'', Volume 77, Issue 11, November 2022, Pages 2908–2921, http..." Tag: Visual edit
  • 08:0008:00, 9 November 2022 diff hist +224‎ Amphotericin B ‎No edit summary current Tag: Visual edit

8 November 2022

7 November 2022

6 November 2022

(newest | oldest) View ( | ) (20 | 50 | 100 | 250 | 500)